Walmart joins blockchain group to track pharmaceuticals

Amy Baxter | | Health Exec | Precision Medicine
Blockchain generic

Retail giant Walmart has joined a blockchain group that aims to track the provenance of pharmaceuticals, the company confirmed to CoinDesk.

The blockchain consortium, MediLedger, includes members such as drugmaker Pfizer and the three largest pharma wholesalers––McKesson, AmerisourceBergen and Cardinal Health.

The move represents another step into the healthcare technology space for Walmart, which has already deepened its presence in the Medicare Advantage market, launched new telehealth services, worked to make over-the-counter drugs more affordable and joined another system for tracking fresh produce with IBM’s Food Trust.

According to CoinDesk, MediLedger uses a version of the ethereum blockchain. Walmart’s addition to the consortium comes ahead of an FDA pilot test of various approaches to creating an interoperable, digitized system for tracking and verifying prescription drugs.

See the full story below:

Walmart Joins Pharmaceutical-Tracking Blockchain Consortium MediLedger

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

AI in Healthcare
4 ways HHS plans to help shape a national strategy for healthcare AI

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.

Cardiovascular Business
FDA announces recall after Philips heart monitor software failed to send alerts—multiple deaths reported

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries.